Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study

Abstract Background Insertable cardiac monitors (ICMs) are increasingly used to evaluate the atrial fibrillation (AF) burden after catheter ablation of AF. BioMonitor III (BM3) is an ICM with a long sensing vector, which enhances sensing capabilities. The AF detection algorithm of the BM3 is based o...

Full description

Bibliographic Details
Main Authors: Amira Assaf, Dominic A. M. J. Theuns, Rafi Sakhi, Rohit E. Bhagwandien, Tamas Szili‐Torok, Sing‐Chien Yap
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Annals of Noninvasive Electrocardiology
Subjects:
Online Access:https://doi.org/10.1111/anec.12960
_version_ 1811216425822453760
author Amira Assaf
Dominic A. M. J. Theuns
Rafi Sakhi
Rohit E. Bhagwandien
Tamas Szili‐Torok
Sing‐Chien Yap
author_facet Amira Assaf
Dominic A. M. J. Theuns
Rafi Sakhi
Rohit E. Bhagwandien
Tamas Szili‐Torok
Sing‐Chien Yap
author_sort Amira Assaf
collection DOAJ
description Abstract Background Insertable cardiac monitors (ICMs) are increasingly used to evaluate the atrial fibrillation (AF) burden after catheter ablation of AF. BioMonitor III (BM3) is an ICM with a long sensing vector, which enhances sensing capabilities. The AF detection algorithm of the BM3 is based on R–R interval variability. Objective To evaluate the performance of the AF detection algorithm of BM3 in patients before and after catheter ablation of AF using simultaneous Holter recordings. Methods In this prospective study, we enrolled patients scheduled for catheter ablation of paroxysmal or persistent AF. After BM3 implantation, patients had a 4 days Holter registration before and 3 months after ablation. All true AF episodes ≥2 min on the Holter were annotated and matched with BM3 detected AF detections. Results Thirty‐one patients were enrolled (mean age 60 ± 8, 74% male, 68% paroxysmal AF). Fifty‐six Holter registrations were performed in 30 patients. Twelve patients demonstrated at least one true AF episode with a total AF duration of 570 h. The AF burden accuracy of BM3 before catheter ablation was 99.6%, with a duration sensitivity of 98.6% and a duration specificity of 99.9%. The AF burden accuracy of BM3 after catheter ablation was 99.8%, with a duration sensitivity of 90.2% and a duration specificity of 99.9%. Overall, the AF burden detected on the Holter and BM3 demonstrated a high Pearson correlation coefficient of 0.996. Conclusion BM3 accurately detects AF burden in patients before and after catheter ablation of AF.
first_indexed 2024-04-12T06:39:00Z
format Article
id doaj.art-4d2a1d33119747d68a33457a585aa779
institution Directory Open Access Journal
issn 1082-720X
1542-474X
language English
last_indexed 2024-04-12T06:39:00Z
publishDate 2022-05-01
publisher Wiley
record_format Article
series Annals of Noninvasive Electrocardiology
spelling doaj.art-4d2a1d33119747d68a33457a585aa7792022-12-22T03:43:47ZengWileyAnnals of Noninvasive Electrocardiology1082-720X1542-474X2022-05-01273n/an/a10.1111/anec.12960Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD studyAmira Assaf0Dominic A. M. J. Theuns1Rafi Sakhi2Rohit E. Bhagwandien3Tamas Szili‐Torok4Sing‐Chien Yap5Department of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsAbstract Background Insertable cardiac monitors (ICMs) are increasingly used to evaluate the atrial fibrillation (AF) burden after catheter ablation of AF. BioMonitor III (BM3) is an ICM with a long sensing vector, which enhances sensing capabilities. The AF detection algorithm of the BM3 is based on R–R interval variability. Objective To evaluate the performance of the AF detection algorithm of BM3 in patients before and after catheter ablation of AF using simultaneous Holter recordings. Methods In this prospective study, we enrolled patients scheduled for catheter ablation of paroxysmal or persistent AF. After BM3 implantation, patients had a 4 days Holter registration before and 3 months after ablation. All true AF episodes ≥2 min on the Holter were annotated and matched with BM3 detected AF detections. Results Thirty‐one patients were enrolled (mean age 60 ± 8, 74% male, 68% paroxysmal AF). Fifty‐six Holter registrations were performed in 30 patients. Twelve patients demonstrated at least one true AF episode with a total AF duration of 570 h. The AF burden accuracy of BM3 before catheter ablation was 99.6%, with a duration sensitivity of 98.6% and a duration specificity of 99.9%. The AF burden accuracy of BM3 after catheter ablation was 99.8%, with a duration sensitivity of 90.2% and a duration specificity of 99.9%. Overall, the AF burden detected on the Holter and BM3 demonstrated a high Pearson correlation coefficient of 0.996. Conclusion BM3 accurately detects AF burden in patients before and after catheter ablation of AF.https://doi.org/10.1111/anec.12960atrial fibrillationBioMonitor IIIcatheter ablationimplantable loop recorderinsertable cardiac monitorpulmonary vein isolation
spellingShingle Amira Assaf
Dominic A. M. J. Theuns
Rafi Sakhi
Rohit E. Bhagwandien
Tamas Szili‐Torok
Sing‐Chien Yap
Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study
Annals of Noninvasive Electrocardiology
atrial fibrillation
BioMonitor III
catheter ablation
implantable loop recorder
insertable cardiac monitor
pulmonary vein isolation
title Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study
title_full Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study
title_fullStr Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study
title_full_unstemmed Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study
title_short Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study
title_sort accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation results of the biovad study
topic atrial fibrillation
BioMonitor III
catheter ablation
implantable loop recorder
insertable cardiac monitor
pulmonary vein isolation
url https://doi.org/10.1111/anec.12960
work_keys_str_mv AT amiraassaf accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy
AT dominicamjtheuns accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy
AT rafisakhi accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy
AT rohitebhagwandien accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy
AT tamasszilitorok accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy
AT singchienyap accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy